Log In
BCIQ
Print this Print this
 

Femathina (MPI-674)

  Manage Alerts
Collapse Summary General Information
Company Meditrina Pharmaceuticals Inc.
DescriptionAromatase inhibitor
Molecular Target Aromatase
Mechanism of ActionAromatase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationEndometrial hyperplasia
Indication DetailsInduce or maintain a thin endometrium in patients with abnormal uterine bleeding (AUB)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today